EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.2.4 | (Z)-N'-((4-chloro-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methylene)-2-oxo-1,2,4a,8a-tetrahydroquinoline-6-carbohydrazide | - |
Homo sapiens | |
2.4.2.4 | 3-(3-(quinoxalin-2-yl)thiazolo[2,3-c][1,2,4]triazol-5-yl)benzene-1,2-diol | - |
Homo sapiens | |
2.4.2.4 | 4-(2,5-difluorobenzyl)-N-(4-(trifluoromethyl)phenyl)piperazine-1-carbothioamide | - |
Homo sapiens | |
2.4.2.4 | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(1-(4-nitrophenyl)ethylidene)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(2,3,4-trihydroxybenzylidene)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(2,3,4-trimethoxybenzylidene)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(2-nitrobenzylidene)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(3,4,5-trimethoxybenzylidene)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(4-(phenoxymethyl)benzylidene)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | 7-deazaxanthine | - |
Homo sapiens | |
2.4.2.4 | additional information | synthesis of isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study, overview. Twenty derivatives of isoquinoline bearing oxadiazole are characterized through different spectroscopic techniques such as HREI-MS, 1H-NMR and 13C-NMR and evaluated for thymidine phosphorylase inhibition, structure-activity relationships study | Homo sapiens | |
2.4.2.4 | N'-(2,4-dichlorobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(2-cyanobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(2-hydroxy-3-methoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(3,5-dichloro-2-hydroxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(3-aminobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(3-cyanobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(3-hydroxy-4-methoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(4-(dimethylamino)benzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(4-chlorobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(4-cyanobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(4-hydroxy-3,5-dimethoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(4-hydroxy-3-methoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(5-bromo-2-methoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens | |
2.4.2.4 | N'-(anthracen-9-ylmethylene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | - |
Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.4 | thymine + 2-deoxy-alpha-D-ribose 1-phosphate | Homo sapiens | - |
thymidine + phosphate | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.4 | Homo sapiens | P19971 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.4 | thymine + 2-deoxy-alpha-D-ribose 1-phosphate | - |
Homo sapiens | thymidine + phosphate | - |
r |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.4.2.4 | 25 | - |
assay at | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.4.2.4 | 7.4 | - |
assay at | Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.4.2.4 | 0.0011 | - |
pH 7.4, 25°C | Homo sapiens | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(2,3,4-trihydroxybenzylidene)benzohydrazide | |
2.4.2.4 | 0.0011 | - |
pH 7.4, 25°C | Homo sapiens | N'-(3-aminobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0024 | - |
pH 7.4, 25°C | Homo sapiens | N'-(3,5-dichloro-2-hydroxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0033 | - |
pH 7.4, 25°C | Homo sapiens | N'-(2,4-dichlorobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0046 | - |
pH 7.4, 25°C | Homo sapiens | N'-(3-hydroxy-4-methoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0053 | - |
pH 7.4, 25°C | Homo sapiens | N'-(4-hydroxy-3,5-dimethoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.006 | - |
pH 7.4, 25°C | Homo sapiens | N'-(4-hydroxy-3-methoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0063 | - |
pH 7.4, 25°C | Homo sapiens | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(2-nitrobenzylidene)benzohydrazide | |
2.4.2.4 | 0.0073 | - |
pH 7.4, 25°C | Homo sapiens | N'-(2-hydroxy-3-methoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0146 | - |
pH 7.4, 25°C | Homo sapiens | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(1-(4-nitrophenyl)ethylidene)benzohydrazide | |
2.4.2.4 | 0.0164 | - |
pH 7.4, 25°C | Homo sapiens | N'-(4-chlorobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0185 | - |
pH 7.4, 25°C | Homo sapiens | N'-(2-cyanobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0188 | - |
pH 7.4, 25°C | Homo sapiens | N'-(4-(dimethylamino)benzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0221 | - |
pH 7.4, 25°C | Homo sapiens | N'-(4-cyanobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0274 | - |
pH 7.4, 25°C | Homo sapiens | N'-(3-cyanobenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0283 | - |
pH 7.4, 25°C | Homo sapiens | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(4-(phenoxymethyl)benzylidene)benzohydrazide | |
2.4.2.4 | 0.0367 | - |
pH 7.4, 25°C | Homo sapiens | N'-(5-bromo-2-methoxybenzylidene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.03868 | - |
pH 7.4, 25°C | Homo sapiens | 7-deazaxanthine | |
2.4.2.4 | 0.0394 | - |
pH 7.4, 25°C | Homo sapiens | N'-(anthracen-9-ylmethylene)-4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)benzohydrazide | |
2.4.2.4 | 0.0473 | - |
pH 7.4, 25°C | Homo sapiens | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(3,4,5-trimethoxybenzylidene)benzohydrazide | |
2.4.2.4 | 0.0546 | - |
pH 7.4, 25°C | Homo sapiens | 4-(5-(isoquinolin-3-yl)-1,3,4-oxadiazol-2-yl)-N'-(2,3,4-trimethoxybenzylidene)benzohydrazide |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.4.2.4 | malfunction | overexpression of thymidine phosphorylase (TP) causes diseases like psoriasis, chronic inflammatory disease, tumor angiogenesis and rheumatoid arthritis etc. The inhibition of this enzyme is vital to secure life from serious threats | Homo sapiens |